CELEX: 62013TA0324
Language: en
Date: 2014-07-16 00:00:00
Title: Case T-324/13: Judgment of the General Court of 16 July 2014  — Endoceutics v OHIM — Merck (FEMIVIA) (Community trade mark — Opposition proceedings — Application for the Community word mark FEMIVIA — Earlier Community word mark FEMIBION — International registration designating the European Community of the earlier figurative mark femibion — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009)

1.9.2014   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 292/43
            
         Judgment of the General Court of 16 July 2014 — Endoceutics v OHIM — Merck (FEMIVIA)
   (Case T-324/13) (1)
   
   ((Community trade mark - Opposition proceedings - Application for the Community word mark FEMIVIA - Earlier Community word mark FEMIBION - International registration designating the European Community of the earlier figurative mark femibion - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))
   2014/C 292/53
   Language of the case: English
   
      Parties
   
   
      Applicant: Endoceutics, Inc. (Quebec, Canada) (represented by: M. Wahlin, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: P. Geroulakos, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM, intervener before the General Court: Merck KGaA (Darmstadt, Germany) (represented by: M. Best, U. Pfleghar and S. Schäffner, lawyers)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of OHIM of 15 April 2013 (Case R 1021/2012-4), concerning opposition proceedings between Merck KGaA and Endoceutics, Inc.
   
      Operative part of the judgment
   
   The Court:
   
               1.
            
            
               Dismisses the action;
            
         
               2.
            
            
               Orders Endoceutics, Inc. to pay the costs.
            
         
      (1)  OJ C 252, 31.8.2013.